Stock SXTP 60 DEGREES PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart 60 Degrees Pharmaceuticals, Inc.

Equities

SXTP

US83006G1040

Market Closed - Nasdaq
Other stock markets
 21:00:00 02/07/2024 BST 		5-day change 1st Jan Change
0.2401 USD -6.94% Intraday chart for 60 Degrees Pharmaceuticals, Inc. -14.34% -76.46%
06-27 60 Degrees Pharmaceuticals, Inc. Announces First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center CI
05-30 60 Degrees Pharmaceuticals, Inc. Enters into an Agreement with Tufts Medical Center in Boston to Conduct the First Clinical Trial of Tafenoquine in Treating Human Babesiosis Patients CI
74b0ccbe4fcb6bb9e9f2.s7eXS98YJvXDYYScN_gEoiwG1h-9Zt1bC_yMTanqF_Q.1O_uGLxXfMGXCeHfY8t9xRl2h02LH5QDJrLAD5GeUZXFw_w9uX90gaUC4w~540734c542cfb9e0cd9a5f26b7109465
  1. Stock Market
  2. Equities
  3. SXTP Stock
  4. Charts 60 Degrees Pharmaceuticals, Inc.
  5. News Chart